4DMedical Ltd's stock surged 6.92% during intraday trading on Thursday, following significant legislative developments concerning its core technology.
The sharp price increase comes after news that a US BILL has been passed directing the Department of Veterans Affairs (VA) to adopt 4D lung imaging technology developed by 4DMedical. This legislative mandate represents a substantial commercial opportunity for the company and validates its medical imaging platform.
Earlier in the trading session, the company had been placed in a trading halt pending an announcement regarding the implications of the US Congress BILL for 4DMedical. The subsequent confirmation of the VA adoption directive triggered the positive market response as investors anticipate increased revenue streams from government healthcare contracts.